IRIS
Di Lorenzo, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 927
SA - Sud America 567
NA - Nord America 348
EU - Europa 172
AF - Africa 45
OC - Oceania 3
Totale 2.062
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 625
BR - Brasile 503
US - Stati Uniti d'America 263
HK - Hong Kong 99
IT - Italia 77
MX - Messico 49
BD - Bangladesh 30
GB - Regno Unito 25
IN - India 24
VN - Vietnam 24
CA - Canada 21
IQ - Iraq 18
AR - Argentina 17
SA - Arabia Saudita 17
CN - Cina 16
NL - Olanda 16
TR - Turchia 15
DE - Germania 14
VE - Venezuela 13
UA - Ucraina 12
ZA - Sudafrica 12
ID - Indonesia 11
UZ - Uzbekistan 11
MA - Marocco 9
EC - Ecuador 8
EG - Egitto 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
RU - Federazione Russa 7
JO - Giordania 6
KE - Kenya 6
PK - Pakistan 6
PY - Paraguay 6
UY - Uruguay 6
ET - Etiopia 5
FR - Francia 5
BO - Bolivia 4
ES - Italia 4
JM - Giamaica 4
AU - Australia 3
BB - Barbados 3
NP - Nepal 3
OM - Oman 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
PE - Perù 2
PT - Portogallo 2
CL - Cile 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
LU - Lussemburgo 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 2.062
Salva come PNG Salva come JPEG
Città #
Singapore 422
Hong Kong 84
Mexico City 40
São Paulo 36
Rome 28
Beijing 16
Naples 14
Chicago 12
Rio de Janeiro 11
Tashkent 11
Belo Horizonte 10
Brasília 10
Dhaka 8
Salvador 8
Baghdad 7
Goiânia 7
Hanoi 7
Ho Chi Minh City 7
Amman 6
Campinas 6
Jeddah 6
Cleveland 5
Curitiba 5
Istanbul 5
Johannesburg 5
João Pessoa 5
Milan 5
Montevideo 5
New York 5
Porto Alegre 5
Bragança Paulista 4
Cairo 4
Cape Town 4
Casablanca 4
Charlotte 4
Contagem 4
Dubai 4
Juiz de Fora 4
Nairobi 4
Nepean 4
Philadelphia 4
Praia Grande 4
Riyadh 4
Santo André 4
Sete Lagoas 4
Taubaté 4
Toronto 4
Uberlândia 4
Vancouver 4
Addis Ababa 3
Anaheim 3
Ankara 3
Atlanta 3
Balneário Camboriú 3
Baltimore 3
Belford Roxo 3
Blumenau 3
Bridgetown 3
Dallas 3
Dammam 3
Delhi 3
Fortaleza 3
Governador Valadares 3
Guarulhos 3
Guayaquil 3
Indianapolis 3
Irecê 3
Jundiaí 3
Lahore 3
Las Vegas 3
Macapá 3
Maracaibo 3
Mariana 3
Orlando 3
Pelotas 3
Recife 3
Ribeirão Preto 3
San Lorenzello 3
Santa Cruz 3
Santa Maria 3
Sobral 3
Sorocaba 3
São Gonçalo 3
Tampa 3
Toledo 3
Valparaíso de Goiás 3
Abbotsford 2
Adana 2
Anápolis 2
Aparecida de Goiânia 2
Ashburn 2
Asunción 2
Bagé 2
Baku 2
Barquisimeto 2
Belém 2
Boardman 2
Bogotá 2
Buenos Aires 2
Calvisano 2
Totale 1.016
Salva come PNG Salva come JPEG
Nome #
Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients 38
Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy 24
A case of renal melanoma metastasis: Description of clinico-pathological features 18
Validation of Psychometric Tools for Assessing Fatigue, Mood, and Sleep Quality: Application in the PREVES-STOP Study. 17
Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle 15
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers 14
Impact of Dietary Supplements on Clinical Outcomes and 2 Quality of Life in Patients with Breast Cancer: A Systematic Review 14
An evolving role for immunotherapy in metastatic RCC 13
Instant messaging in cancer care 13
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 12
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 12
Management of AIDS-related Kaposi's sarcoma 12
Focus on localized laryngeal amyloidosis: Management of five cases 12
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy 12
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 12
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors 12
KIDNEY CANCER Overall survival is an unsuitable primary end point 12
Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study 12
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 11
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial 11
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis 11
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study 11
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 11
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial 11
Chirurgia conservativa e qualità di vita in pazienti con carcinoma renale localizzato. 11
INCREASED EXPRESSION OF THE AUTOCRINE MOTILITY FACTOR IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH CLEAR CELL – RENAL CELL CARCINOMA 11
Combination therapy for metastatic renal cell carcinoma 11
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 11
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience 10
Predictors of Residual T1 High Grade on Re- Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer 10
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 10
Incidence of fatigue and low dose of corticosteroids in patients receiving systemic treatment: a metanalysis of randomized trials 10
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 10
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142 10
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis 10
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 10
An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples (vol 12, pg 1491, 2011) 10
Cisplatin- Versus Non-Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin 10
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) 10
Medical expulsive treatment of distal-ureteral stones using tamsulosin: A single-center experience 10
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 9
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 9
PCA3 COMPARISON WITH PROSTATE HEALTH INDEX (PHI) IN REPEAT BIOPSY PATIENTS 9
LOOKING AT THE PROSTATES OF PATIENTS WITH BLADDER CANCER: A THOUGHTFUL EXERCISE 9
Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma. 9
Optimal Management of Metastatic Castration-Resistant Prostate Cancer:Highlights from a European Expert Consensus Panel 9
Involvement of growth factor receptors of the epidermal growth factor receptor (EGFR) family in prostate cancer development and in the progression to androgen- independence. 9
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection 9
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen 9
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond 9
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 9
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 9
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 9
Expression of HECA-452 in parapsoriasis and mycosis fungoides 9
New perspectives in the therapy of castration resistant prostate cancer 9
Hypercastration in prostate cancer 9
Optimal management of a patient with recurrent nasopharyngeal carcinoma 9
Thermal and fluid dynamic behaviors of confined laminar impinging slot jets with nanofluids 9
Outcomes associated with first-line PD-1 and PD-L1 inhibitors vs. sunitinib in patients with renal cell cancer with sarcomatoid features: a systematic review and meta-analysis 9
A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review 9
Computed-Tomography-Structured Reporting in Middle Ear Opacification: Surgical Results and Clinical Considerations From a Large Retrospective Analysis 9
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study 9
A Prognostic Model for Patients With Metastatic Renal Cell Cancer: What's New? 9
The role of immunotherapy in oncology 9
Second-line treatment for renal cell cancer 9
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: A retrospective Italian survey 9
ADVERSE EVENTS 1 OF IMMUNE CHECKPOINT INHIBITORS THERAPYFOR UROLOGIC CANCER PATIENTS IN CLINICAL TRIALS: A COLLABORATIVE SYSTEMATIC REVIEW AND META ANALYSIS 9
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 9
Nature's hidden gem: quercitrin's promising role in preventing prostate and bladder cancer 9
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion 9
The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer 9
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario 9
Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial 9
Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study 8
TUMORI UROLOGICI: PROSTATA, RENE E VESCICA 8
The use of tamsulosin in the medical treatment of ureteral calculi: Where do we stand? 8
Squamous cell carcinoma of the scrotum: A look beyond the chimneystacks 8
Docetaxel Rechallenge in Castration-Resistant Prostate Cancer: Scientific Legitimacy of Common Clinical Practice 8
Immunotherapy for the treatment of prostate cancer 8
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis 8
Coronavirus disease (COVID-19) in Italy: Analysis of risk factors and proposed remedial measures 8
TUMORI UROLOGICI: TUMORI DEL TESTICOLO, PROSTATA, RENE E VESCICA 8
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: A multicenter study 8
Expression of proto-oncogene c-kit in high risk prostate cancer 8
Gemcitabine Versus Bacille Calmette-Guerin After Initial Bacille Calmette-Guerin Failure in Non-Muscle-Invasive Bladder Cancer A Multicenter Prospective Randomized Trial 8
Hormone Refractory Prostate Cancer (HRPC): Present and future approaches of therapy 8
Matrix metalloproteinase-2 and-9 in the urine of prostate cancer patients 8
Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology (I-O). A real-world study on behalf of Meet-URO group (MeetUro-7b) 8
Does perioperative systemic therapy represent the optimal therapeutic paradigm in organ-confined, muscle-invasive urothelial carcinoma? 8
Concurrent Chemoradiotherapy for Men With Locally Advanced Penile Squamous Cell Carcinoma 8
Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme 8
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 8
The evolving landscape in advanced penile cancer 8
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy 8
Correlation Between Serum Prostate-specific Antigen and Cancer Volume in Prostate Glands of Different Sizes EDITORIAL COMMENT 8
New Agents for Prostate Cancer. 8
Myrtucommulone Production by a Strain of Neofusicoccum australe Endophytic in Myrtle. 8
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone 8
Synergistic Combination of Quercetin and Mafosfamide in the Treatment of Bladder Cancer Cells 8
Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study 8
Totale 1.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.392
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.165 0 0 0 28 338 19 114 372 101 60 553 580
2025/2026259 259 0 0 0 0 0 0 0 0 0 0 0
Totale 2.424